Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/22990
Title: A phase 3 randomized, double-blind, placebo-controlled trial of ganitumab or placebo in combination with gemcitabine as first-line therapy for metastatic adenocarcinoma of the pancreas: the GAMMA trial.
Authors: 
Keywords: 
Mesh: 
Issue Date: May-2015
Citation: Ann. Oncol..2015 May;(26)5:921-7
Abstract: This double-blind, phase 3 study assessed the efficacy and safety of ganitumab combined with gemcitabine as first-line treatment of metastatic pancreatic cancer.
PMID: 25609246
URI: https://hdl.handle.net/20.500.12530/22990
Rights: openAccess
Appears in Collections:Fundaciones e Institutos de Investigación > IIS H. U. Ramón y Cajal > Artículos

Files in This Item:
File Description SizeFormat 
PMC4804122.pdf186.01 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.